Obesity and insulin resistance associated with lower plasma vitamin B 12 in PCOS

Reproductive BioMedicine Online

Volumn 19, Issue 5, 2009, Pages 721-726

  Kaya, Cemil ^a   Cengiz, Sevim Dinçer ^b   Satiroǧlu, Hakan ^a  

^a UFUK UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Folate; Homocysteine; Insulin resistance; Obesity; PCOS

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 74949084454     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.06.005     Document Type: Article

References (29)

1. 12 in plasma. Nature 198, 200.
2. Ashwell M, Chinn S, Stalley S, Garrow JS 1982 Female fat distribution a simple classification based on two circumference measurements. International Journal of Obesity 6, 143-152.
3. Azziz R, Marin C, Hog L et al. 2005 Healthcare-related economic burden of the polycystic ovary syndrome during the reproductive lifespan. Journal of Clinical Endocrinology and Metabolism 90, 4650-4658.
4. Balen AH, Laven JS, Tan SL, Dewailly D 2003 Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 9, 505-511.
5. Belli SH, Graffigna MN, Oneta A et al. 2004 Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Fertility and Sterility 81, 624-629.
6. Boulman N, Levy Y, Leiba R et al. 2004 Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 89, 2160-2165.
7. Boxmeer JC, Montserrate Brouns R et al. 2008 Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertility and Sterility 89, 1766-1770.
8. Crosignani PG, Walter V, Colombo M, Ragni G 2002 Resumption of fertility with diet in overweight. Reproductive BioMedicine Online 5, 60-64.
9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT et al. 1999 A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 84, 4006-4011.
10. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800.
11. Ebisch IMW, Peters WH, Thomas CM et al. 2006 Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Human Reproduction 21, 1725-1733.
12. Ehrman DA, Liljenguist DR, Kazsa K et al. 2006 Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 91, 48-53.
13. Expert Committee on the Diagnosis and Classification 2003 Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 22, 141-146.
14. Ferriman D, Gallway JD 1961 Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 21, 1440-1447.
15. Fonseca V, Guba SC, Fink LM 1999 Hyperhomocysteinaemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocrine Reviews 20, 738-759.
16. Kaya C, Cengiz SD, Berker B et al. 2009 Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective, randomized study. Fertility and Sterility 92, 635-642.
17. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 84, 165-169.
18. Loverro G, Lorusso F, Mei L et al. 2002 The plasma homocysteine levels are increased in polycystic ovary syndrome. Gynecologic and Obstetric Investigation 53, 157-162.
19. McCarty MF 2000 Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute-phase induction of pyridoxal phosphatase activity. Medical Hypotheses 55, 289-293.
20. Matthews DR, Hosker JP, Rudenski AS et al. 1985 Homeostasis model assessment: insulin resistance and (cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
21. Orio F, Palomba S, Di Biase S et al. 2003 Homocysteine levels and C677T polymorphism of methylentetrahydrofolate reductase in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88, 673-679.
22. Pasquali R, Gambineri A 2004 Role of changes in dietary habits in polycystic ovary syndrome. Reproductive BioMedicine Online 8, 431-439.
23. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertility and Sterility 81, 19-25.
24. Schacter M, Raziel A, Friedler S et al. 2003 Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Human Reproduction 8, 721-727.
25. Selhub J, Miller JW 1992 The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. American Journal of Clinical Nutrition 55, 131-138.
26. 12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. European Journal of Endocrinology 151, 483-489.
27. Steegers-Theunissen RP, Steegers EA, Thomas CM et al. 1993 Study on the presence of homocysteine in ovarian follicular fluid. Fertility and Sterility 60, 1006-1010.
28. Talbott E, Guzick D, Clerici A et al. 1995 Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis Thrombosis and Vascular Biology 95, 821-826.
29. Yarali H, Yildirir A, Aybar F et al. 2001 Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome. Fertility and Sterility 76, 511-516.